Latest news
Fresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles - News-Press NOWNews-Press NOW · Mon, 10 Aug 2026 22:35:12 GMT(tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles - Business WireBusiness Wire · Mon, 10 Aug 2026 22:34:00 GMTFresenius Kabi Issues Nationwide Recall of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL Vials Due to Presence of Glass Particles - The Killeen Daily HeraldThe Killeen Daily Herald · Mon, 10 Aug 2026 22:34:00 GMTLabel Mix-Up Prompts Morphine Sulfate Injection Recall - Clinical Pain AdvisorClinical Pain Advisor · Mon, 10 Aug 2026 04:00:00 GMTMislabeled Morphine Injection Lot Recalled Nationwide Over Potential Overdose Risk - NTD NewsNTD News · Fri, 07 Aug 2026 20:41:24 GMTFresenius Kabi recalls morphine lot that could lead to death - Fierce PharmaFierce Pharma · Fri, 07 Aug 2026 13:29:33 GMTFresenius Announces FDA Approval of Rituximab Biosimilar for the U.S. Market - Business WireBusiness Wire · Mon, 03 Aug 2026 07:00:00 GMT